FibrosIX is a biotechnology company develops drugs to prevent lung fibrosis in cancer patients.

Biotechnology

Health Care

FibrosIX

FibrosIX's headquarters in East Lansing, MI, United States

Kendell M. Pawelec

Scott D. Larsen

The leadership team at FibrosIX has a history of experience in academia, entrepreneurship, and consulting. They have also been involved in editing a second edition of Bone Repair Biomaterials and are currently president of ASPET. They have also been professors at Michigan State University and the University of Michigan, as well as research fellows at Pfizer and Associate Directors at Pharmacia.

FibrosIX

Org chart

Teams

Leadership Team

Offices

FibrosIX

Org chart

Teams

Leadership Team

Offices

Related companies